POS-100 OUTPATIENT PHARMACOLOGIC TREATMENTS FOR RAAS INHIBITOR-RELATED HYPERKALEMIA AND THE RISK OF RECURRENCE

• G. HUNDEMER,
• R. Talarico,
• M. Sood

Affiliations

G. HUNDEMER

Ottawa Hospital - Riverside Campus, Department of Medicine, Division of Nephrology, Ottawa, Canada

R. Talarico

Institute for Clinical Evaluative Sciences, Ottawa Hospital Research Institute, Ottawa, Canada

M. Sood

Institute for Clinical Evaluative Services, Department of Medicine, Division of Nephrology, Ottawa, Canada